
Professor, Department of Surgical Sciences
Contact Information
Patient Care Related:Biosketch
Kevin A. Ault, MD, is a board-certified obstetrician-gynecologist. He is a professor in the Division of Obstetrics and Gynecology at Western Michigan University Homer Stryker M.D. School of Medicine (WMed). He served as department chair of the Department of Obstetrics and Gynecology at WMed from 2022-2024. He is a graduate of Butler University and Indiana University School of Medicine, both in Indianapolis, Indiana. He completed his residency in obstetrics and gynecology at Ohio State University Wexner Medical Center in Columbus, Ohio. He is a Fellow of the American College of Obstetricians and Gynecologists, and a Fellow of the Infectious Disease Society of America. His clinical and research interests include women's health and infectious diseases.
-
Education and Training
- Fellowship 1994, Infectious Diseases, Medical Center, University of Kansas
- Residency 1992, Obstetrics and Gynecology, Ohio State University College of Medicine
- MD 1988, Indiana University School of Medicine
- BS 1984, Zoology and Environmental Studies, College of Liberal Arts and Sciences, Butler University
-
Research
- maternal immunization
- Vulvar Diseases
- Vaginitis
- Vaccines
- Cervical Intraepithelial Neoplasia
-
Publications
Murthy N., Patricia Wodi A., Bernstein H., Ault K.A. Recommended Adult Immunization Schedule, United States, 2022* Annals of Internal Medicine. 2024;177:432-445.
Amaral E., Amaral E., Money D., Jamieson D., Pasupathy D., Pasupathy D., Aronoff D., Aronoff D., Jacobsson B., Lizcano E.I.O., Lizcano E.I.O., Money D., Ault K., Jamieson D., Kan N., Martins L., Buga E., Megh M., Cam A., Newman M., Serruya S. Vaccination during pregnancy: A golden opportunity to embrace International Journal of Gynecology and Obstetrics. 2023
Ault K.A., Kachikis A.B. Infectious Diseases in Obstetrics and Gynecology: Moving Forward in the Twenty-First Century Obstetrics and Gynecology Clinics of North America. 2023;50:xvii-xviii.
Murthy N., Wodi A.P., Bernstein H., Ault K.A. Recommended Adult Immunization Schedule, United States, 2022 Annals of Internal Medicine. 2023;176:432-443.
Murthy N., Wodi A.P., McNally V., Cineas S., Ault K. Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2023 Morbidity and Mortality Weekly Report. 2023;72:141-144.
Wodi A.P., Murthy N., McNally V., Cineas S., Ault K. Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger — United States, 2023 Morbidity and Mortality Weekly Report. 2023;72:137-140.
Dudley M.Z., Omer S.B., O’Leary S.T., Limaye R.J., Ellingson M.K., Spina C.I., Brewer S.E., Bednarczyk R.A., Chamberlain A.T., Malik F., Frew P.M., Church-Balin C., Riley L.E., Ault K.A., Orenstein W.A., Halsey N.A., Salmon D.A. MomsTalkShots, tailored educational app, improves vaccine attitudes: a randomized controlled trial BMC Public Health. 2022;22
Murthy N., Wodi A.P., Bernstein H., Ault K.A. Recommended Adult Immunization Schedule, United States, 2022 Annals of Internal Medicine. 2022;175(3):432-443.
Murthy N., Wodi A.P., Bernstein H., McNally V., Cineas S., Ault K. Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2022 Morbidity and Mortality Weekly Report. 2022;71(7):229-233.
Omer S.B., O'Leary S.T., Bednarczyk R.A., Ellingson M.K., Spina C.I., Dudley M.Z., Chamberlain A.T., Limaye R.J., Brewer S.E., Frew P.M., Malik F.A., Orenstein W., Halsey N., Ault K., Salmon D.A. Multi-tiered intervention to increase maternal immunization coverage: A randomized, controlled trial Vaccine. 2022;40:4955-4963.
Redmond M.L., Mayes P., Morris K., Ramaswamy M., Ault K.A., Smith S.A. Learning from maternal voices on COVID-19 vaccine uptake: Perspectives from pregnant women living in the Midwest on the COVID-19 pandemic and vaccine Journal of Community Psychology. 2022;50(6):2630-2643.
Weng M.K., Doshani M., Khan M.A., Frey S., Ault K., Moore K.L., Hall E.W., Morgan R.L., Campos-Outcalt D., Wester C., Nelson N.P. Universal Hepatitis B Vaccination in Adults Aged 19-59 Years: Updated Recommendations of the Advisory Committee on Immunization Practices - United States, 2022 Morbidity and Mortality Weekly Report. 2022;71(13):477-483.
Weng M.K., Doshani M., Khan M.A., Frey S., Ault K., Moore K.L., Hall E.W., Morgan R.L., Campos-Outcalt D., Wester C., Nelson N.P. Universal hepatitis B vaccination in adults aged 19–59 years: Updated recommendations of the advisory committee on immunization practices—United States, 2022 American Journal of Transplantation. 2022;22(6):1714-1720.
Wodi A.P., Murthy N., Bernstein H., McNally V., Cineas S., Ault K. Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger — United States, 2022 Morbidity and Mortality Weekly Report. 2022;71(7):234-237.
Donders G.G.G., Grinceviciene S., Haldre K., Lonnee-Hoffmann R., Donders F., Tsiakalos A., Adriaanse A., de Oliveira J.M., Ault K., Mendling W. Isidog consensus guidelines on covid-19 vaccination for women before, during and after pregnancy Journal of Clinical Medicine. 2021;10(13)
Freedman M.S., Ault K., Bernstein H. Advisory committee on immunization practices recommended immunization schedule for adults aged 19 years or older - United States, 2021 Morbidity and Mortality Weekly Report. 2021;70(6):193-196.
Freedman M.S., Bernstein H., Ault K.A. Recommended adult immunization schedule, united states, 2021 Annals of Internal Medicine. 2021;174(3):374-384.
Ramaswamy M., Satterwhite C.L., Lipnicky A., Emerson A., Griffin P., Ash D., Ault K. Recommendations for Delivering COVID-19 Vaccine in Jails: Evidence from Kansas, Iowa, Nebraska, and Missouri American Journal of Public Health. 2021;111(6):1035-1039.
Sullivan-Blum Z., Stites S., Kennedy P., Swenson M., Ault K., Alt M., Dietz C., Rotert P., Ramaswamy M. Stakeholder Perspectives on Linking HIV Pre-Exposure Prophylaxis with Human Papillomavirus Vaccine AIDS Patient Care and STDs. 2021;35(3):65-68.
Wendel S.O., Snow J.A., Bastian T., Brown L., Hernandez C., Burghardt E., Kahn A., Murthy V., Neill D., Smith Z.C., Ault K., Tawfik O., Wu C., Wallace N.A. High risk α-HPV E6 impairs translesion synthesis by blocking POLη induction Cancers. 2021;13(1):1-22.
Wodi A.P., Ault K., Hunter P., McNally V., Szilagyi P.G., Bernstein H. Advisory committee on immunization practices recommended immunization schedule for children and adolescents aged 18 years or younger - United States, 2021 Morbidity and Mortality Weekly Report. 2021;70(6):189-192.
Freedman M., Kroger A., Hunter P., Ault K.A., Romero J.R., Cohn A., Atmar R.L., Bahta L., Bell B.P., Bernstein H., Frey S.E., Lee G.M., McNally V.V., Poehling K.A., Sánchez P.J., Szilagyi P., Talbot H.K., Epling J., Fryhofer S., Howell M., Koenigs L.P., Léger M.M., Lett S.M., Rittle C., Schaffner W., Schmader K., Sperling R., Weber D., Aleshire N., Arvay M., Bridges C., Byrd K., Desai M., Dooling K., Fiebelkorn A.P., Grohskopf L., Havers F., Koppaka R., Liang J., Marin M., Markowitz L., Matanock A., Mbaeyi S., MacNeil J., Oliver S., Patel M., Patel P., Pilishvili T., Redmon G., Robinson C., Schillie S., Strikas R.A., Weinbaum C., Williams W.W., Woods L.D., Harriman K., Hopkins R.H., Lanzi M.C., Peterson D., Tan L. Recommended adult immunization schedule, United States, 2020 Annals of Internal Medicine. 2020;172(5):337-347.
Freedman M.S., Hunter P., Ault K., Kroger A. Advisory committee on immunization practices recommended immunization schedule for adults aged 19 years or older - United States, 2020 Morbidity and Mortality Weekly Report. 2020;69(5):133-135.
Lai L., Ault K., Rouphael N., Beck A., Domjahn B., Xu Y., Anderson E.J., Cheng A., Nakamura A., Hoagland R.J., Kelley C., Edupuganti S., Mask K., Nesin M., Unger E.R., Panicker G., David H., Mulligan M.J. Duration of cellular and humoral responses after quadrivalent human papillomavirus vaccination in healthy female adults with or without prior type 16 and/or 18 exposure Vaccines. 2020;8(3)
Chamberlain A.T., Limaye R.J., O'Leary S.T., Frew P.M., Brewer S.E., Spina C.I., Ellingson M.K., Dudley M.Z., Orenstein W.A., Donnelly M.A., Riley L.E., Ault K.A., Salmon D.A., Omer S.B. Development and acceptability of a video-based vaccine promotion tutorial for obstetric care providers Vaccine. 2019;37(19):2532-2536.
Kachikis A., Eckert L.O., Walker C., Bardají A., Varricchio F., Lipkind H.S., Diouf K., Huang W.T., Mataya R., Bittaye M., Cutland C., Boghossian N.S., Mallett Moore T., McCall R., King J., Mundle S., Munoz F.M., Rouse C., Gravett M., Katikaneni L., Ault K., Klein N.P., Roberts D.J., Kochhar S., Chescheir N. Chorioamnionitis: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data Vaccine. 2019;37(52):7610-7622.
Webb S., Kelly P.J., Wickliffe J., Ault K., Ramaswamy M. Validating self-reported cervical cancer screening among women leaving jails PLoS ONE. 2019;14(7)
Allison M., Musser B., Satterwhite C., Ault K., Kelly P., Ramaswamy M. Human papillomavirus vaccine knowledge and intention among adult inmates in Kansas, 2016–2017 American Journal of Public Health. 2018;108(8):1000-1002.
Ault K., Riley L. Response to Donahue et al. 2017 in press article Vaccine. 2018;36(17):2230.
Frew P.M., Randall L.A., Malik F., Limaye R.J., Wilson A., O'Leary S.T., Salmon D., Donnelly M., Ault K., Dudley M.Z., Fenimore V.L., Omer S.B. Clinician perspectives on strategies to improve patient maternal immunization acceptability in obstetrics and gynecology practice settings Human Vaccines and Immunotherapeutics. 2018;14(7):1548-1557.
Garland S.M., Joura E.A., Ault K.A., Bosch F.X., Brown D.R., Castellsagué X., Ferenczy A., Ferris D.G., Giuliano A.R., Hernandez-Avila M., Huh W.K., Iversen O.E., Kjaer S.K., Kurman R.J., Luna J., Monsonego J., Muñoz N., Paavonen J., Pitisuttihum P., Ronnett B.M., Steben M., Stoler M.H., Wheeler C.M., Wiley D.J., Perez G., Saah A.J., Luxembourg A., Li S., DiNubile M.J., Wagner M., Velicer C. Human Papillomavirus Genotypes from Vaginal and Vulvar Intraepithelial Neoplasia in Females 15-26 Years of Age Obstetrics and Gynecology. 2018;132(2):261-270.
Munoz F.M., Jackson L.A., Swamy G.K., Edwards K.M., Frey S.E., Stephens I., Ault K., Winokur P., Petrie C.R., Wolff M., Patel S.M., Keitel W.A. Safety and immunogenicity of seasonal trivalent inactivated influenza vaccines in pregnant women Vaccine. 2018;36(52):8054-8061.
Huh W.K., Joura E.A., Giuliano A.R., Iversen O.E., de Andrade R.P., Ault K.A., Bartholomew D., Cestero R.M., Fedrizzi E.N., Hirschberg A.L., Mayrand M.H., Ruiz-Sternberg A.M., Stapleton J.T., Wiley D.J., Ferenczy A., Kurman R., Ronnett B.M., Stoler M.H., Cuzick J., Garland S.M., Kjaer S.K., Bautista O.M., Haupt R., Moeller E., Ritter M., Roberts C.C., Shields C., Luxembourg A. Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16–26 years: a randomised, double-blind trial The Lancet. 2017;390(10108):2143-2159.
Kriss J.L., Frew P.M., Cortes M., Malik F.A., Chamberlain A.T., Seib K., Flowers L., Ault K.A., Howards P.P., Orenstein W.A., Omer S.B. Evaluation of two vaccine education interventions to improve pertussis vaccination among pregnant African American women: A randomized controlled trial Vaccine. 2017;35(11):1551-1558.
Bednarczyk R.A., Figueroa-Downing D., Ault K. Reply American Journal of Obstetrics and Gynecology. 2016;214(5):667-668.
Bednarczyk R.A., Figueroa-Downing D., Ault K. Why is it appropriate to recommend human papillomavirus vaccination as cervical cancer prevention? American Journal of Obstetrics and Gynecology. 2016;214(4):490-493.
Castellsagué X., Ault K.A., Bosch F.X., Brown D., Cuzick J., Ferris D.G., Joura E.A., Garland S.M., Giuliano A.R., Hernandez-Avila M., Huh W., Iversen O.E., Kjaer S.K., Luna J., Monsonego J., Muñoz N., Myers E., Paavonen J., Pitisuttihum P., Steben M., Wheeler C.M., Perez G., Saah A., Luxembourg A., Sings H.L., Velicer C. Human papillomavirus detection in cervical neoplasia attributed to 12 high-risk human papillomavirus genotypes by region Papillomavirus Research. 2016;2:61-69.
Chamberlain A.T., Berkelman R.L., Ault K.A., Rosenberg E.S., Orenstein W.A., Omer S.B. Trends in reasons for non-receipt of influenza vaccination during pregnancy in Georgia, 2004-2011 Vaccine. 2016;34(13):1597-1603.
Chamberlain A.T., Seib K., Ault K.A., Rosenberg E.S., Frew P.M., Cortes M., Whitney E.A.S., Berkelman R.L., Orenstein W.A., Omer S.B. Impact of a multi-component antenatal vaccine promotion package on improving knowledge, attitudes and beliefs about influenza and Tdap vaccination during pregnancy Human Vaccines and Immunotherapeutics. 2016;12(8):2017-2024.
Waxman A.G., Buenconsejo-Lum L.E., Cremer M., Feldman S., Ault K.A., Cain J.M., Diaz M.L. Cervical Cancer Screening in the United States-Affiliated Pacific Islands: Options and Opportunities Journal of Lower Genital Tract Disease. 2016;20(1):97-104.
Chamberlain A.T., Seib K., Ault K.A., Orenstein W.A., Frew P.M., Malik F., Cortés M., Cota P., Whitney E.A.S., Flowers L.C., Berkelman R.L., Omer S.B. Factors associated with intention to receive influenza and tetanus, diphtheria, and acellular pertussis (Tdap) vaccines during pregnancy: A focus on vaccine hesitancy and perceptions of disease severity and vaccine safety PLoS Currents. 2015;7(OUTBREAKS)
Chamberlain A.T., Seib K., Ault K.A., Rosenberg E.S., Frew P.M., Cortés M., Whitney E.A.S., Berkelman R.L., Orenstein W.A., Omer S.B. Improving influenza and Tdap vaccination during pregnancy: A cluster-randomized trial of a multi-component antenatal vaccine promotion package in late influenza season Vaccine. 2015;33(30):3571-3579.
Huh W., Ault K., Chelmow D., Davey D., Goulart R., Garcia F., Kinney W., Massad L., Mayeaux E., Saslow D., Schiffman M., Wentzensen N., Lawson H., Einstein M. Use of primary high-risk human papillomavirus testing for cervical cancer screening: Interim clinical guidance Gynecologic Oncology. 2015;136(2):178-182.
Huh W.K., Ault K.A., Chelmow D., Davey D.D., Goulart R.A., Garcia F.A., Kinney W.K., Massad L.S., Mayeaux E.J., Saslow D., Schiffman M., Wentzensen N., Lawson H.W., Einstein M.H. Use of primary high-risk human papillomavirus testing for cervical cancer screening: Interim clinical guidance Journal of Lower Genital Tract Disease. 2015;19(2):91-96.
Huh W.K., Ault K.A., Chelmow D., Davey D.D., Goulart R.A., Garcia F.A.R., Kinney W.K., Massad L.S., Mayeaux E.J., Saslow D., Schiffman M., Wentzensen N., Lawson H.W., Einstein M.H. Use of primary high-risk human papillomavirus testing for cervical cancer screening: Interim clinical guidance Obstetrics and Gynecology. 2015;125(2):330-337.
Pahud B.A., Ault K.A. The Expanded Impact of Human Papillomavirus Vaccine Infectious Disease Clinics of North America. 2015;29(4):715-724.
Rosen T., Nelson A., Ault K. Imiquimod cream 2.5% and 3.75% applied once daily to treat external genital warts in men Cutis. 2015;96(4):277-282.
Saftlas A.F., Spracklen C.N., Ryckman K.K., Stockdale C.K., Penrose K., Ault K., Rubenstein L.M., Pinto L.A. Influence of a loop electrosurgical excision procedure (LEEP) on levels of cytokines in cervical secretions Journal of Reproductive Immunology. 2015;109:74-83.
Ault K.A. Doctor, it hurts Obstetrics and Gynecology. 2014;123(2):223-224.
Frew P.M., Saint-Victor D.S., Isaacs M.B., Kim S., Swamy G.K., Sheffield J.S., Edwards K.M., Villafana T., Kamagate O., Ault K. Recruitment and retention of pregnant women into clinical research trials: An overview of challenges, facilitators, and best practices Clinical Infectious Diseases. 2014;59:S400-S407.
Joura E.A., Ault K.A., Bosch F.X., Brown D., Cuzick J., Ferris D., Garland S.M., Giuliano A.R., Hernandez-Avila M., Huh W., Iversen O.E., Kjaer S.K., Luna J., Miller D., Monsonego J., Munoz N., Myers E., Paavonen J., Pitisuttithum P., Steben M., Wheeler C.M., Perez G., Saah A., Luxembourg A., Sings H.L., Velicer C. Attribution of 12 high-risk human papillomavirus genotypes to infection and cervical disease Cancer Epidemiology Biomarkers and Prevention. 2014;23(10):1997-2008.
van Otterloo J., Seib K., Ault K.A., Omer S.B. Women’s health providers as vaccine providers in public health emergencies Journal of Reproductive Medicine. 2014;59(4):401-408.
Fogelson N.S., Rubin Z.A., Ault K.A. Beyond likes and tweets: An in-depth look at the physician social media landscape Clinical Obstetrics and Gynecology. 2013;56(3):495-508.
Gattoc L., Nair N., Ault K. Human Papillomavirus Vaccination. Current Indications and Future Directions. Obstetrics and Gynecology Clinics of North America. 2013;40(2):177-197.
Munoz F.M., Sheffield J.S., Beigi R.H., Read J.S., Swamy G.K., Jevaji I., Rasmussen S.A., Edwards K.M., Fortner K.B., Patel S.M., Spong C.Y., Ault K., Heine R.P., Nesin M. Research on vaccines during pregnancy: Protocol design and assessment of safety Vaccine. 2013;31(40):4274-4279.
Richards J.L., Hansen C., Bredfeldt C., Bednarczyk R.A., Steinhoff M.C., Adjaye-Gbewonyo D., Ault K., Gallagher M., Orenstein W., Davis R.L., Omer S.B. Neonatal outcomes after antenatal influenza immunization during the 2009 H1N1 influenza pandemic: Impact on preterm birth, birth weight, and small for gestational age birth Clinical Infectious Diseases. 2013;56(9):1216-1222.
Sheffield J.S., Munoz F.M., Beigi R.H., Rasmussen S.A., Edwards K.M., Read J.S., Heine R.P., Ault K.A., Swamy G.K., Jevaji I., Spong C.Y., Fortner K.B., Patel S.M., Nesin M. Research on vaccines during pregnancy: Reference values for vital signs and laboratory assessments Vaccine. 2013;31(40):4264-4273.
Ault K., Heine R., Riley L. Programmatic and research priorities for improving influenza immunization of pregnant women American Journal of Obstetrics and Gynecology. 2012;207(3 SUPPL.)
Bednarczyk R.A., Davis R., Ault K., Orenstein W., Omer S.B. Sexual activity-related outcomes after human papillomavirus vaccination of 11- to 12-year-olds Pediatrics. 2012;130(5):798-805.
Brotman R.M., Bradford L.L., Conrad M., Gajer P., Ault K., Peralta L., Forney L.J., Carlton J.M., Abdo Z., Ravel J. Association between trichomonas vaginalis and vaginal bacterial community composition among reproductive-age women Sexually Transmitted Diseases. 2012;39(10):807-812.
Joura E.A., Garland S.M., Paavonen J., Ferris D.G., Perez G., Ault K.A., Huh W.K., Sings H.L., James M.K., Haupt R.M. Effect of the human papillomavirus (HPV) quadrivalent vaccine in a subgroup of women with cervical and vulvar disease: Retrospective pooled analysis of trial data BMJ (Online). 2012;344(7851)
Link-Gelles R., Chamberlain A.T., Schulkin J., Ault K., Whitney E., Seib K., Omer S.B. Missed opportunities: A national survey of obstetricians about attitudes on maternal and infant immunization Maternal and Child Health Journal. 2012;16(9):1743-1747.
Wiley D., Masongsong E., Lu S., Heather L. S., Salem B., Giuliano A., Ault K., Haupt R., Brown D. Behavioral and sociodemographic risk factors for serological and DNA evidence of HPV6, 11, 16, 18 infections Cancer Epidemiology. 2012;36(3)
Ault K., Brown D. Advancing human papillomavirus research with a rhesus monkey model Journal of the National Cancer Institute. 2011;103(9):703.
Ault K.A. Cervical cancer prevention: Better tests, better tools, and more equitable outcomes Journal of the National Cancer Institute. 2011;103(18):1352-1353.
Ault K.A., Joura E.A., Kjaer S.K., Iversen O.E., Wheeler C.M., Perez G., Brown D.R., Koutsky L.A., Garland S.M., Olsson S.E., Tang G.W.K., Ferris D.G., Paavonen J., Steben M., Bosch F.X., Majewski S., Muñoz N., Sings H.L., Harkins K., Rutkowski M.A., Haupt R.M., Garner E.I.O. Adenocarcinoma in situ and associated human papillomavirus type distribution observed in two clinical trials of a quadrivalent human papillomavirus vaccine International Journal of Cancer. 2011;128(6):1344-1353.
Baker D.A., Ferris D.G., Martens M.G., Fife K.H., Tyring S.K., Edwards L., Nelson A., Ault K., Trofatter K.F., Liu T., Levy S., Wu J. Imiquimod 3.75 cream applied daily to treat anogenital warts: Combined results from women in two randomized, placebo-controlled studies Infectious Diseases in Obstetrics and Gynecology. 2011;2011
Castellsagué X., Mũoz N., Pitisuttithum P., Ferris D., Monsonego J., Ault K., Luna J., Myers E., Mallary S., Bautista O.M., Bryan J., Vuocolo S., Haupt R.M., Saah A. End-of-study safety, immunogenicity, and efficacy of quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine in adult women 24-45 years of age British Journal of Cancer. 2011;105(1):28-37.
Fort V., Makin M., Siegler A., Ault K., Rochat R. Barriers to cervical cancer screening in Mulanje, Malawi: A qualitative study Patient Preference and Adherence. 2011;5:125-131.
Lehtinen M., Ault K.A., Lyytikainen E., Dillner J., Garland S.M., Ferris D.G., Koutsky L.A., Sings H.L., Lu S., Haupt R.M., Paavonen J. Chlamydia trachomatis infection and risk of cervical intraepithelial neoplasia Sexually Transmitted Infections. 2011;87(5):372-376.
Ravel J., Gajer P., Abdo Z., Schneider G.M., Koenig S.S.K., McCulle S.L., Karlebach S., Gorle R., Russell J., Tacket C.O., Brotman R.M., Davis C.C., Ault K., Peralta L., Forney L.J. Vaginal microbiome of reproductive-age women Proceedings of the National Academy of Sciences of the United States of America. 2011;108(SUPPL. 1):4680-4687.
Dillner J., Kjaer S.K., Wheeler C.M., Sigurdsson K., Iversen O.E., Hernandez-Avila M., Perez G., Brown D.R., Koutsky L.A., Tay E.H., García P., Ault K.A., Garland S.M., Leodolter S., Olsson S.E., Tang G.W.K., Ferris D.G., Paavonen J., Lehtinen M., Steben M., Bosch F.X., Joura E.A., Majewski S., Muñoz N., Myers E.R., Villa L.L., Taddeo F.J., Roberts C., Tadesse A., Bryan J.T., Maansson R., Lu S., Vuocolo S., Hesley T.M., Barr E., Haupt R. Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: Randomised controlled trial BMJ (Online). 2010;341(7766):239.
Forney L.J., Gajer P., Williams C.J., Schneider G.M., Koenig S.S.K., McCulle S.L., Karlebach S., Brotman R.M., Davis C.C., Ault K., Ravel J. Comparison of self-collected and physician-collected vaginal swabs for microbiome analysis Journal of Clinical Microbiology. 2010;48(5):1741-1748.
Munoz N., Kjaer S.K., Sigurdsson K., Iversen O.E., Hernandez-Avila M., Wheeler C.M., Perez G., Brown D.R., Koutsky L.A., Tay E.H., Garcia P.J., Ault K.A., Garland S.M., Leodolter S., Olsson S.E., Tang G.W.K., Ferris D.G., Paavonen J., Steben M., Bosch F.X., Dillner J., Huh W.K., Joura E.A., Kurman R.J., Majewski S., Myers E.R., Villa L.L., Taddeo F.J., Roberts C., Tadesse A., Bryan J.T., Lupinacci L.C., Giacoletti K.E.D., Sings H.L., James M.K., Hesley T.M., Barr E., Haupt R.M. Impact of Human Papillomavirus (HPV)-6/11/16/18 Vaccine on All HPV-Associated Genital Diseases in Young Women Journal of the National Cancer Institute. 2010;102(5):325-339.
Ault K.A., Bocchini J.A. Human Papillomaviruses Principles and Practice of Pediatric Infectious Disease: Third Edition. 2009:1055-1058.
Brown D.R., Kjaer S.K., Sigurdsson K., Iversen O.E., Mauricio H.A., Wheeler C.M., Perez G., Koutsky L.A., Tay E.H., Garcia P., Ault K.A., Garland S.M., Leodolter S., Olsson S.E., Tang G.W.K., Ferris D.G., Paavonen J., Steben M., Bosch F.X., Dillner J., Joura E.A., Kurman R.J., Majewski S., Muñoz N., Myers E.R., Villa L.L., Taddeo F.J., Roberts C., Tadesse A., Bryan J., Lupinacci L.C., Giacoletti K.E.D., Sings H.L., James M., Hesley T.M., Barra E. The impact of quadrivalent human papillomavirus (HPV; Types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naive women aged 16-26 years Journal of Infectious Diseases. 2009;199(7):926-935.
Garland S., Ault K., Gall S., Paavonen J., Sings H., Ciprero K., Saah A., Marino D., Ryan D., Radley D., Zhou H., Haupt R., Garner E. Pregnancy and infant outcomes in the clinical trials of a human papillomavirus type 6/11/16/18 vaccine: A combined analysis of five randomized controlled trials Obstetrics and Gynecology. 2009;114(6):1179-1188.
King M., Poya H., Rao J., Natarajan S., Butch A.W., Aziz N., Kok S., Chang M.H., Lyons J.M., Ault K., Kelly K.A. CXCL13 expression in Chlamydia trachomatis infection of the female reproductive tract Drugs of Today. 2009;45(SUPPL. B):125-134.
Kjaer S.K., Sigurdsson K., Iversen O.E., Hernandez-Avila M., Wheeler C.M., Perez G., Brown D.R., Koutsky L.A., Eng H.T., García P., Ault K.A., Garland S.M., Leodolter S., Olsson S.E., Tang G.W.K., Ferris D.G., Paavonen J., Lehtinen M., Steben M., Bosch F.X., Dillner J., Joura E.A., Majewski S., Muñoz N., Myers E.R., Villa L.L., Taddeo F.J., Roberts C., Tadesse A., Bryan J., Maansson R., Lu S., Vuocolo S., Hesley T.M., Saah A., Barr E., Haupt R.M. A pooled analysis of continued prophylactic efficacy of quadrivalent human papillomavirus (types 6/11/16/18) vaccine against high-grade cervical and external genital lesions Cancer Prevention Research. 2009;2(10):868-878.
Muñoz N., Manalastas R., Pitisuttithum P., Tresukosol D., Monsonego J., Ault K., Clavel C., Luna J., Myers E., Hood S., Bautista O., Bryan J., Taddeo F.J., Esser M.T., Vuocolo S., Haupt R.M., Barr E., Saah A. Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24-45 years: a randomised, double-blind trial The Lancet. 2009;373(9679):1949-1957.
Olsson S.E., Kjaer S.K., Sigurdsson K., Iversen O.E., Hernandez-Avila M., Wheeler C.M., Perez G., Brown D.R., Koutsky L.A., Tay E.H., García P., Ault K.A., Garland S.M., Leodolter S., Tang G.W.K., Ferris D.G., Paavonen J., Lehtinen M., Steben M., Bosch F.X., Dillner J., Joura E.A., Majewski S., Muñoz N., Myers E.R., Villa L.L., Taddeo F.J., Roberts C., Tadesse A., Bryan J., Maansson R., Vuocolo S., Hesley T.M., Saah A., Barr E., Haupt R.M. Evaluation of quadrivalent HPV 6/11/16/18 vaccine efficacy against cervical and anogenital disease in subjects with serological evidence of prior vaccine type HPV infection Human Vaccines. 2009;5(10):696-704.
Tamma P.D., Ault K.A., del Rio C., Steinhoff M.C., Halsey N.A., Omer S.B. Safety of influenza vaccination during pregnancy American Journal of Obstetrics and Gynecology. 2009;201(6):547-552.
Wheeler C.M., Kjaer S.K., Sigurdsson K., Iversen O.E., Mauricio H.A., Perez G., Brown D.R., Koutsky L.A., Tay E.H., García P., Ault K.A., Garland S.M., Leodolter S., Olsson S.E., Tang G.W.K., Ferris D.G., Paavonen J., Steben M., Bosch F.X., Dillner J., Joura E.A., Kurman R.J., Majewski S., Muñoz N., Myers E.R., Villa L.L., Taddeo F.J., Roberts C., Tadesse A., Bryan J., Lupinacci L.C., Giacoletti K.E.D., James M., Vuocolo S., Hesley T.M., Barra E. The impact of quadrivalent human papillomavirus (HPV; Types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine hpv types in sexually active women aged 16-26 years Journal of Infectious Diseases. 2009;199(7):936-944.
Ault K. Human papillomavirus vaccines: An update for gynecologists Clinical Obstetrics and Gynecology. 2008;51(3):527-532.
Ault K. Interview Therapy. 2008;5(3):279-281.
Ault K. New antibiotics and vaccines in obstetric practice Clinical Obstetrics and Gynecology. 2008;51(3):485.
Joura E.A., Kjaer S.K., Wheeler C.M., Sigurdsson K., Iversen O.E., Hernandez-Avila M., Perez G., Brown D.R., Koutsky L.A., Tay E.H., García P., Ault K.A., Garland S.M., Leodolter S., Olsson S.E., Tang G.W.K., Ferris D.G., Paavonen J., Lehtinen M., Steben M., Bosch X., Dillner J., Kurman R.J., Majewski S., Muñoz N., Myers E.R., Villa L.L., Taddeo F.J., Roberts C., Tadesse A., Bryan J., Lupinacci L.C., Giacoletti K.E.D., Lu S., Vuocolo S., Hesley T.M., Haupt R.M., Barr E. HPV antibody levels and clinical efficacy following administration of a prophylactic quadrivalent HPV vaccine Vaccine. 2008;26(52):6844-6851.
Paavonen J., Paavonen J., Villa L., Munoz N., Perez G., Krüger Kjaer S., Lehtinen M., Sigurdsson K., Hernandez-Avila M., Iversen O.E., Garcia P., Majewski S., Tay E.H., Bosch F.X., Dillner J., Olsson S.E., Ault K., Brown D., Ferris D., Koutsky L., Kurman R., Myers E. Baseline demographic characteristics of subjects enrolled in international quadrivalent HPV (types 6/11/16/18) vaccine clinical trials Current Medical Research and Opinion. 2008;24(6):1623-1634.
Wright T.C., Huh W.K., Monk B.J., Smith J.S., Ault K., Herzog T.J. Age considerations when vaccinating against HPV Gynecologic Oncology. 2008;109(2 SUPPL.)
Ault K. Human papillomavirus vaccines and the potential for cross-protection between related HPV types Gynecologic Oncology. 2007;107(2 SUPPL.)
Ault K. Long-term efficacy of human papillomavirus vaccination Gynecologic Oncology. 2007;107(2 SUPPL.)
Ault K., Insinga R., Haupt R., Lupinacci L., Barr E. Effects of quadrivalent human papillomavirus vaccination - Authors' reply Lancet. 2007;370(9592):1032-1033.
Ault K., Reisinger K. Programmatic issues in the implementation of an HPV vaccination program to prevent cervical cancer International Journal of Infectious Diseases. 2007;11(SUPPL. 2)
Ault K.A. Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomised clinical trials Lancet. 2007;369(9576):1861-1868.
Fraser C., Tomassini J., Xi L., Golm G., Watson M., Giuliano A., Barr E., Ault K. Modeling the long-term antibody response of a human papillomavirus (HPV) virus-like particle (VLP) type 16 prophylactic vaccine Vaccine. 2007;25(21):4324-4333.
Oberley R.E., Goss K.L., Hoffmann D.S., Ault K.A., Neff T.L., Ramsey K.H., Snyder J.M. Regulation of surfactant protein D in the mouse female reproductive tract in vivo Molecular Human Reproduction. 2007;13(12):863-868.
Villa L.L., Perez G., Kjaer S.K., Paavonen J., Lehtinen M., Muñoz N., Sigurdsson K., Hernandez-Avila M., Skjeldestad F.E., Thoresen S., García P., Majewski S., Dillner J., Olsson S.E., Eng H.T., Bosch F.X., Ault K.A., Brown D.R., Ferris D.G., Koutsky L.A., Kurman R.J., Myers E.R., Barr E., Boslego J., Bryan J., Esser M.T., Gause C.K., Hesley T.M., Lupinacci L.C., Sings H.L., Taddeo F.J., Thornton A.R. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions New England Journal of Medicine. 2007;356(19):1915-1927.
Villa L.L., Perez G., Kjaer S.K., Paavonen J., Paavonen J., Lehtinen M., Muñoz N., Sigurdsson K., Sigurdsson K., Hernandez-Avila M., Skjeldestad F.E., Thoresen S., García P., Majewski S., Dillner J., Olsson S.E., Tay E.H., Xavier Bosch F., Ault K.A., Brown D.R., Ferris D.G., Koutsky L.A., Kurman R.J., Myers E.R., Barr E., Boslego J., Bryan J., Esser M.T., Gause C.K., Hesley T.M., Lupinacci L.C., Sings H.L., Taddeo F.J., Thornton A.R., Boulos M., Cox J.T., Langmark F., Modlin J., Muñoz A., Odlind V., Wilkinson E., Ferenczy A., Kurman R., Ronnett B., Stoler M., Andreoni G., Bahamondes L., Camargos A., Costa R., De Andrade R., Fedrizzi E., Ferriani R., Gonçalves M., Laginha F., Mendonça J., Moreira E., Nonnenmacher B., Taborda W., Zanetta D., Ardila J., Balcazar N., Maldonado I., Revollo F., Ruiz A., Andersen E.S., Djursing H., Hansen T., Jørgensen J.J., Nilas L., Ottesen B., Petersen L.K., Thomsen S.G., Toftager-Larsen K., Apter D., Kekki M., Kuortti M., Lahti L., Lindroos Y., Lunnas T., Palmroth J., Lazcano E., Zertuche J., Dalaker K., Eriksen B., Ernø L.E., Fiane B., Hesla K., Myhre Isachsen M., Iversen O.E., Kasin K., Kristoffersen M., Lunde T., Nordmark P.T., Nygaard T., Onsrud M., Riis-Johannessen G., Schiøtz H., Skjeldestad F.E., Sundhagen H., Sviggum O. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions Obstetrical and Gynecological Survey. 2007;62:578-579.
Villa L.L., Perez G., Kjær S.K., Paavonen J., Lehtinen M., Muñoz N., Sigurdsson K., Hernandez-Avila M., Iversen O.E., Thoresen S., García P.J., Majewski S., Eng H.T., Bosch F.X., Dillner J., Olsson S.E., Ault K.A., Brown D.R., Ferris D.G., Koutsky L.A., Kurman R.J., Myers E.R., Barr E., Boslego J., Bryan J., Esser M.T., Hesley T.M., Nelson M., Railkar R., James M., Sattler C., Taddeo F.J., Thornton A.R., Vuocolo S.C. Prophylactic efficacy of a quadrivalent human papillomavirus (HPV) vaccine in women with virological evidence of HPV Infection Journal of Infectious Diseases. 2007;196(10):1438-1446.
Ault K. Epidemiology and natural history of human papillomavirus infections in the female genital tract Infectious Diseases in Obstetrics and Gynecology. 2006;2006
Ault K.A. Vaccines for the prevention of human papillomavirus and associated gynecologic diseases: A review Obstetrical and Gynecological Survey. 2006;61(6 SUPPL. 1)
Bauer H.M., Ault K. Human papillomavirus: Current prevalence and future protection Sexually Transmitted Diseases. 2006;33(8):509-511.
Ferris D.G., Fife K.H., Ault K.A. Human papillomavirus quadrivalent (types 6, 11, 16, 18) recombinant vaccine (Gardasil®) Drugs. 2006;66(9):1272.
Hollmer C., Essmann M., Ault K., Larsen B. Adherence and blocking of Candida albicans to cultured vaginal epithelial cells: Treatments to decrease adherence Infectious Diseases in Obstetrics and Gynecology. 2006;2006
Kennedy C., Burns B., Ault K. Does rubella immunity predict measles immunity? A serosurvey of pregnant women Infectious Diseases in Obstetrics and Gynecology. 2006;2006
Mao C., Koutsky L., Ault K., Wheeler C., Brown D., Wiley D., Alvarez F., Bautista O., Jansen K., Barr E. Efficacy of human papillomavirus-16 vaccine to prevent cervical intraepithelial neoplasia: A randomized controlled trial Obstetrics and Gynecology. 2006;107(1):18-27.
Villa L.L., Ault K.A., Giuliano A.R., Costa R.L.R., Petta C.A., Andrade R.P., Brown D.R., Ferenczy A., Harper D.M., Koutsky L.A., Kurman R.J., Lehtinen M., Malm C., Olsson S.E., Ronnett B.M., Skjeldestad F.E., Steinwall M., Stoler M.H., Wheeler C.M., Taddeo F.J., Yu J., Lupinacci L., Railkar R., Marchese R., Esser M.T., Bryan J., Jansen K.U., Sings H.L., Tamms G.M., Saah A.J., Barr E. Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18 Vaccine. 2006;24(27-28):5571-5583.
Ault K. A bivalent vaccine prevented incident and persistent infection with HPV types 16 and 18 in young women: Commentary Evidence-based Obstetrics and Gynecology. 2005;7(4):205-206.
Ault K., Ness R., Genuis S.J., Genuis S.K. Condoms and reproductive health [2] (multiple letters) American Journal of Obstetrics and Gynecology. 2005;193(2):591-592.
Ault K.A., Allen H.K., Phillips S.L., Zimmerman M.B., Klingelhutz A.J. Telomerase activity as a potential diagnostic marker for triage of abnormal pap smears Journal of Lower Genital Tract Disease. 2005;9(2):93-99.
Einwalter L.A., Ritchie J.M., Ault K.A., Smith E.M. Gonorrhea and chlamydia infection among women visiting family planning clinics: Racial variation in prevalence and predictors Perspectives on Sexual and Reproductive Health. 2005;37(3):135-140.
Hodnett E.D., Hodnett E.D., Hannah M.E., Hewson S., Whyte H., Amankwah K., Cheng M., Gafni A., Guselle P., Helewa M., Hutton E., Kung R., McKay D., Saigal S., Willan A., Hannah W.J., Ross S., Savransky R., Dunaiewsky A., Palermo M.S.F., Wizenberg S.E., Varela D.M., Monaco A., Jaime M., Martin R.d.L., Olcese E., Iannelli P., D'Abboua O., Nardin J.C., Abalos E., Leroux A., Duarte M., Crowther C., Wilkinson C., King J.F., Thompson S., Flenady V., Palmer J.R., Davidson L., Bullard M., Smoleniec J., White J., Margolis K., Haran M., Smith B., Roche J.B., Broome J., Lambert M., Draddy K., Child A.G., Peat B., Phipps H., Davis G.K., Alcock D., Schmaltz L.E.P.R., de Souza G.R., Almeida P.B.L., Viggiano M.G.C., Vidal A.C., Gaio D.S.M., Ayub A.C.K., da Silva S.O.C., Crook L., Hunt B., Docrat Z., MacKinnon C., Campbell D., Lange I.R., Pollard J., Swaby C., Martyn P., Brown R.J., Hensman L., Morcos F., Gillespie L., Demianczuk N.N., Penttinen E., Huband D.M., Martinini D., van der Starn E., Luther E.R., Byrd-Chaulk A., Lamont D.A., Gallen J., Burlock S., Gardner J., Davies G.A.L., Ottenhof C., Natale R., Watson L., Watson M., Duemler M., Ejiwunmi R., Mantay E., Alfenore C., Campbell N., Bala P., Himaya A., Boland J., Harrison W.E. Mothers' Views ofTheir Childbirth Experiences 2 Years Mter Planned Caesarean Versus Planned Vaginal Birth for Breech Presentation at Term, in the International Randomized Term Breech Trial Journal of Obstetrics and Gynaecology Canada. 2005;27(3):224-231.
Oberley R., Goss K., Dahmoush L., Ault K., Crouch E., Snyder J. A role for surfactant protein D in innate immunity of the human prostate Prostate. 2005;65(3):241-251.
Peterson M.L., Ault K., Kremer M.J., Klingelhutz A.J., Davis C.C., Squier C.A., Schlievert P.M. The innate immune system is activated by stimulation of vaginal epithelial cells with Staphylococcus aureus and toxic shock syndrome toxin 1 Infection and Immunity. 2005;73(4):2164-2174.
Villa L.L., Costa R.L.R., Petta C.A., Andrade R.P., Ault K.A., Giuliano A.R., Wheeler C.M., Koutsky L.A., Malm C., Lehtinen M., Skjeldestad F.E., Olsson S.E., Steinwall M., Brown D.R., Kurman R.J., Ronnett B.M., Stoler M.H., Ferenczy A., Harper D.M., Tamms G.M., Yu J., Lupinacci L., Railkar R., Taddeo F.J., Jansen K.U., Esser M.T., Sings H.L., Saah A.J., Barr E. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: A randomised double-blind placebo-controlled multicentre phase II efficacy trial Lancet Oncology. 2005;6(5):271-278.
Villa L.L., Costa R.L.R., Petta C.A., Andrade R.P., Ault K.A., Giuliano A.R., Wheeler C.M., Koutsky L.A., Malm C., Lehtinen M., Skjeldestad F.E., Olsson S.E., Steinwall M., Brown D.R., Kurman R.J., Ronnett B.M., Stoler M.H., Ferenczy A., Harper D.M., Tamms G.M., Yu J., Lupinacci L., Railkar R., Taddeo F.J., Jansen K.U., Esser M.T., Sings H.L., Saah A.J., Barr E., Bosch F.X. A quadrivalent vaccine prevented persistent infection and disease associated with HPV types 6, 11, 16, and 18 Evidence-based Obstetrics and Gynecology. 2005;7(3):160-161.
Ault K. Management quandary. An unusual case of STI in a teenager. Journal of pediatric and adolescent gynecology. 2004;17(4):293-295.
Ault K.A., Giuliano A.R., Edwards R.P., Tamms G., Kim L.L., Smith J.F., Jansen K.U., Allende M., Taddeo F.J., Skulsky D.M., Barr E. A phase I study to evaluate a human papillomavirus (HPV) type 18 L1 VLP vaccine Vaccine. 2004;22(23-24):3004-3007.
Oberley R., Ault K., Neff T., Khubchandani K., Crouch E., Snyder J. Surfactant proteins A and D enhance the phagocytosis of Chlamydia into THP-1 cells American Journal of Physiology - Lung Cellular and Molecular Physiology. 2004;287(2 31-2)
Oberley R.E., Goss K.L., Ault K.A., Crouch E.C., Snyder J.M. Surfactant protein D is present in the human female reproductive tract and inhibits Chlamydia trachomatis infection Molecular Human Reproduction. 2004;10(12):861-870.
Quint E., Bacon J., Ault K. An unusual case of STI in a teenager Journal of Pediatric and Adolescent Gynecology. 2004;17(4):293-295.
Raley J.C., Followwill K.A., Zimet G.D., Ault K.A. Gynecologists' attitudes regarding human papilloma virus vaccination: A survey of Fellows of the American College of Obstetricians and Gynecologists Infectious Disease in Obstetrics and Gynecology. 2004;12(3-4):127-133.
Ault K. Human papillomavirus infections: Diagnosis, treatment, and hope for a vaccine Obstetrics and Gynecology Clinics of North America. 2003;30(4):809-817.
Ault K. Virus-like particles as a potential vaccine for human papillomavirus Papillomavirus Report. 2003;14(2):47-51.
Koutsky L., Ault K., Wheeler C., Brown D., Barr E., Alvarez F., Chiacchierini L., Jansen K., Wu T., Boyd D. HPV-16 vaccine prevented persistent HPV-16 infection and the development of HPV-16 related cervical neoplasia Evidence-based Obstetrics and Gynecology. 2003;5(1):42-43.
Ramsey K.H., Shaba N., Cohoon K.P., Ault K.A. Imiquimod does not affect shedding of viable chlamydiae in a murine model of Chlamydia trachomatis genital tract infection Infectious Disease in Obstetrics and Gynecology. 2003;11(2):81-87.
Ault K.A., Kelly K.A., Ruther P.E., Izzo A.A., Izzo L.S., Sigar I.M., Ramsey K.H. Chlamydia trachomatis enhances the expression of matrix metalloproteinases in an in vitro model of the human fallopian tube infection American Journal of Obstetrics and Gynecology. 2002;187(5):1377-1383.
Koutsky L.A., Ault K.A., Wheeler C.M., Brown D.R., Barr E., Alvarez F.B., Chiacchierini L.M., Jansen K.U. A controlled trial of a human papillomavirus type 16 vaccine New England Journal of Medicine. 2002;347(21):1645-1651.
Edwards J.L., Brown E.J., Ault K.A., Apicella M.A. The role of complement receptor 3 (CR3) in Neisseria gonorrhoeae infection of human cervical epithelia Cellular Microbiology. 2001;3(9):611-622.
Hilger T.M., Smith E.M., Ault K. Predictors of Chlamydia trachomatis infection among women attending rural midwest family planning clinics Infectious Diseases in Obstetrics and Gynecology. 2001;9(1):3-8.
Kelly K.A., Natarajan S., Ruther P., Wisse A., Chang M.H., Ault K.A. Chlamydia trachomatis infection induces mucosal addressin cell adhesion molecule-1 and vascular cell adhesion molecule-1, providing an immunologic link between the fallopian tube and other mucosal tissues Journal of Infectious Diseases. 2001;184(7):885-891.
Lowe M.P., Ault K.A., Sood A.K. Recurrent carcinoma in situ of a neovagina Gynecologic Oncology. 2001;80(3):403-404.
Edwards J., Shao J., Ault K., Apicella M. Neisseria gonorrhoeae elicits membrane ruffling and cytoskeletal rearrangements upon infection of primary human endocervical and ectocervical cells Infection and Immunity. 2000;68(9):5354-5363.
LaVerda D., Albanese L., Ruther P., Morrison S., Morrison R., Ault K., Byrne G. Seroreactivity to Chlamydia trachomatis Hsp10 correlates with severity of human genital tract disease Infection and Immunity. 2000;68(1):303-309.
Ault K.A., Statland B.D., Smith King M.M., Dozier D.I.L., Joachims M.L., Gunter J. Antibodies to the chlamydial 60 kilodalton heat shock protein in women with tubal factor infertility Infectious Diseases in Obstetrics and Gynecology. 1998;6(4):163-167.
Ault K.A., Tawfik O.W., Smith-King M.M., Gunter J., Terranova P.F. Tumor necrosis factor-α response to infection with Chlamydia trachomatis in human fallopian tube organ culture American Journal of Obstetrics and Gynecology. 1996;175(5):1242-1245.
Luchi M., Beauregard C., Ault K., Hinthorn D. Blindness in a Woman With Human Immunodeficiency Virus Infection and Syphilis Infectious Diseases in Obstetrics and Gynecology. 1995;3(5):198-201.
Ault K.A. Vaginal flora as the source for neonatal early onset haemophilus influenzae sepsis Pediatric Infectious Disease Journal. 1994;13(3):243.
Ault K., Gabbe S., O'Shaughnessy R., Ayers L. Three Cases of Haemophilus Influenzae Amnionitis American Journal of Perinatology. 1993;10(5):378-380.
Ault K.A., Ault K.A., Kennedy M., Kennedy M., Seoud M.A.F., Reiss R., Reiss R., Seoud M.A.F. Maternal and Neonatal Infection With Salmonella eidelberg: A Case Report Infectious Diseases in Obstetrics and Gynecology. 1993;1(1):46-48.
Ault K.A., Faro S. Pelvic inflammatory disease: Current diagnostic criteria and treatment guidelines Postgraduate Medicine. 1993;93(2)
Ault K.A., Faro S. Practical Guidelines for Preventing Congenital Syphilis Infectious Diseases in Obstetrics and Gynecology. 1993;1(3):115-117.
Ault K.A., Faro S. Viruses, bacteria, and protozoans in pregnancy: A sample of each Clinical Obstetrics and Gynecology. 1993;36(4):878-885.
Weinberger M., Ault K.A., Vinicor F. Prospective reimbursement and diabetes mellitus: Impact upon glycemic control and utilization of health services Medical Care. 1988;26(1):77-83.
Ault K., Sheta M., Vinicor F. Diabetic ketoacidosis: changing views of treatment. Indiana medicine : the journal of the Indiana State Medical Association. 1987;80(8):719-725.